Annual Cash & Cash Equivalents
$34.76 M
-$11.26 M-24.47%
December 31, 2023
Summary
- As of February 7, 2025, VXRT annual cash & cash equivalents is $34.76 million, with the most recent change of -$11.26 million (-24.47%) on December 31, 2023.
- During the last 3 years, VXRT annual cash & cash equivalents has fallen by -$92.11 million (-72.61%).
- VXRT annual cash & cash equivalents is now -84.03% below its all-time high of $217.61 million, reached on December 29, 2007.
Performance
VXRT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$22.04 M
-$21.25 M-49.09%
September 30, 2024
Summary
- As of February 7, 2025, VXRT quarterly cash and cash equivalents is $22.04 million, with the most recent change of -$21.25 million (-49.09%) on September 30, 2024.
- Over the past year, VXRT quarterly cash and cash equivalents has dropped by -$10.41 million (-32.09%).
- VXRT quarterly cash and cash equivalents is now -89.87% below its all-time high of $217.61 million, reached on December 29, 2007.
Performance
VXRT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VXRT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.5% | -32.1% |
| 3 y3 years | -72.6% | -54.5% |
| 5 y5 years | +203.4% | -54.5% |
VXRT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.8% | at low | -84.7% | at low |
| 5 y | 5-year | -75.8% | +156.9% | -86.8% | +62.9% |
| alltime | all time | -84.0% | >+9999.0% | -89.9% | >+9999.0% |
Vaxart Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $22.04 M(-49.1%) |
| Jun 2024 | - | $43.28 M(+61.9%) |
| Mar 2024 | - | $26.73 M(-23.1%) |
| Dec 2023 | $34.76 M(-24.5%) | $34.76 M(+7.1%) |
| Sep 2023 | - | $32.45 M(-25.0%) |
| Jun 2023 | - | $43.28 M(-10.6%) |
| Mar 2023 | - | $48.43 M(+5.3%) |
| Dec 2022 | $46.01 M(-68.0%) | $46.01 M(-9.4%) |
| Sep 2022 | - | $50.77 M(-44.5%) |
| Jun 2022 | - | $91.47 M(-25.9%) |
| Mar 2022 | - | $123.40 M(-14.2%) |
| Dec 2021 | $143.75 M(+13.3%) | $143.75 M(-14.0%) |
| Sep 2021 | - | $167.23 M(+1.2%) |
| Jun 2021 | - | $165.27 M(+5.1%) |
| Mar 2021 | - | $157.31 M(+24.0%) |
| Dec 2020 | $126.87 M(+838.0%) | $126.87 M(-4.9%) |
| Sep 2020 | - | $133.44 M(+200.6%) |
| Jun 2020 | - | $44.39 M(+48.7%) |
| Mar 2020 | - | $29.86 M(+120.8%) |
| Dec 2019 | $13.53 M(+18.1%) | $13.53 M(-30.8%) |
| Sep 2019 | - | $19.56 M(+20.3%) |
| Jun 2019 | - | $16.26 M(+94.1%) |
| Mar 2019 | - | $8.37 M(-26.9%) |
| Dec 2018 | $11.46 M(-35.3%) | $11.46 M(-36.1%) |
| Sep 2018 | - | $17.92 M(-25.1%) |
| Jun 2018 | - | $23.92 M(+36.7%) |
| Mar 2018 | - | $17.50 M(-40.5%) |
| Dec 2017 | - | $29.40 M(+50.0%) |
| Sep 2017 | - | $19.60 M(+10.7%) |
| Jun 2017 | $17.70 M(-64.4%) | $17.70 M(+50.0%) |
| Mar 2017 | - | $11.80 M(-69.0%) |
| Dec 2016 | - | $38.10 M(-17.0%) |
| Sep 2016 | - | $45.90 M(-7.6%) |
| Jun 2016 | $49.70 M(+11.2%) | $49.70 M(+62.4%) |
| Mar 2016 | - | $30.60 M(-21.5%) |
| Dec 2015 | - | $39.00 M(-13.9%) |
| Sep 2015 | - | $45.30 M(+1.3%) |
| Jun 2015 | $44.70 M(-45.3%) | $44.70 M(-27.3%) |
| Mar 2015 | - | $61.50 M(-3.5%) |
| Dec 2014 | - | $63.70 M(+10.4%) |
| Sep 2014 | - | $57.70 M(-29.4%) |
| Jun 2014 | $81.70 M(+22.3%) | $81.70 M(+2.0%) |
| Mar 2014 | - | $80.10 M(+55.8%) |
| Dec 2013 | - | $51.40 M(-15.5%) |
| Sep 2013 | - | $60.80 M(-9.0%) |
| Jun 2013 | $66.80 M(-29.2%) | $66.80 M(-4.9%) |
| Mar 2013 | - | $70.27 M(-5.2%) |
| Dec 2012 | - | $74.11 M(+11.7%) |
| Sep 2012 | - | $66.32 M(-28.4%) |
| Jun 2012 | - | $92.65 M(-2.3%) |
| Mar 2012 | - | $94.88 M(+0.6%) |
| Dec 2011 | $94.31 M(+76.1%) | $94.31 M(+1.5%) |
| Sep 2011 | - | $92.95 M(+7.3%) |
| Jun 2011 | - | $86.62 M(+46.6%) |
| Mar 2011 | - | $59.09 M(+10.3%) |
| Dec 2010 | $53.56 M(-10.0%) | $53.56 M(+43.7%) |
| Sep 2010 | - | $37.28 M(+14.9%) |
| Jun 2010 | - | $32.45 M(-78.0%) |
| Mar 2010 | - | $147.71 M(+148.2%) |
| Dec 2009 | $59.51 M(-44.1%) | $59.51 M(+111.4%) |
| Sep 2009 | - | $28.15 M(-73.9%) |
| Jun 2009 | - | $107.66 M(-5.7%) |
| Mar 2009 | - | $114.19 M(+7.3%) |
| Dec 2008 | $106.44 M(-51.1%) | $106.44 M(-30.1%) |
| Sep 2008 | - | $152.25 M(-5.2%) |
| Jun 2008 | - | $160.55 M(-18.8%) |
| Mar 2008 | - | $197.72 M(-9.1%) |
| Dec 2007 | $217.61 M(+152.4%) | $217.61 M(+178.8%) |
| Sep 2007 | - | $78.04 M(+13.9%) |
| Jun 2007 | - | $68.52 M(-19.1%) |
| Mar 2007 | - | $84.66 M(-1.8%) |
| Dec 2006 | $86.23 M | $86.23 M(+169.3%) |
| Sep 2006 | - | $32.02 M(+2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $31.12 M(-39.4%) |
| Mar 2006 | - | $51.40 M(-49.5%) |
| Dec 2005 | $101.76 M(+7.4%) | $101.76 M(+84.1%) |
| Sep 2005 | - | $55.26 M(-41.4%) |
| Jun 2005 | - | $94.35 M(+89.4%) |
| Mar 2005 | - | $49.81 M(-47.4%) |
| Dec 2004 | $94.76 M(-18.1%) | $94.76 M(-14.5%) |
| Sep 2004 | - | $110.78 M(-5.3%) |
| Jun 2004 | - | $117.00 M(+0.2%) |
| Mar 2004 | - | $116.78 M(+0.9%) |
| Dec 2003 | $115.76 M(+123.7%) | $115.76 M(+341.0%) |
| Sep 2003 | - | $26.25 M(-55.2%) |
| Jun 2003 | - | $58.61 M(+24.9%) |
| Mar 2003 | - | $46.94 M(-9.3%) |
| Dec 2002 | $51.74 M(-60.6%) | $51.74 M(+18.8%) |
| Sep 2002 | - | $43.54 M(-6.8%) |
| Jun 2002 | - | $46.71 M(-63.0%) |
| Mar 2002 | - | $126.12 M(-3.9%) |
| Dec 2001 | $131.19 M(+8342.2%) | $131.19 M(+0.1%) |
| Sep 2001 | - | $131.03 M(+6605.9%) |
| Jun 2001 | - | $1.95 M(-13.9%) |
| Mar 2001 | - | $2.27 M(+46.1%) |
| Dec 2000 | $1.55 M(+92.8%) | $1.55 M(+1.0%) |
| Sep 2000 | - | $1.54 M(-3.0%) |
| Jun 2000 | - | $1.59 M(-44.8%) |
| Mar 2000 | - | $2.87 M(+256.6%) |
| Dec 1999 | $806.00 K(-19.4%) | $806.00 K(+34.3%) |
| Sep 1999 | - | $600.00 K(-45.5%) |
| Jun 1999 | - | $1.10 M(-45.0%) |
| Mar 1999 | - | $2.00 M(+100.0%) |
| Dec 1998 | $1.00 M(-70.6%) | $1.00 M(+42.9%) |
| Sep 1998 | - | $700.00 K(-61.1%) |
| Jun 1998 | - | $1.80 M(+50.0%) |
| Mar 1998 | - | $1.20 M(-64.7%) |
| Dec 1997 | $3.40 M(-81.6%) | $3.40 M(-57.5%) |
| Sep 1997 | - | $8.00 M(+48.1%) |
| Jun 1997 | - | $5.40 M(-73.4%) |
| Mar 1997 | - | $20.30 M(+9.7%) |
| Dec 1996 | $18.50 M(+362.5%) | $18.50 M(+25.0%) |
| Sep 1996 | - | $14.80 M(+134.9%) |
| Jun 1996 | - | $6.30 M(-71.7%) |
| Mar 1996 | - | $22.30 M(+457.5%) |
| Dec 1995 | $4.00 M(+100.0%) | $4.00 M(+66.7%) |
| Sep 1995 | - | $2.40 M(+26.3%) |
| Jun 1995 | - | $1.90 M(+5.6%) |
| Mar 1995 | - | $1.80 M(-10.0%) |
| Dec 1994 | $2.00 M(+150.0%) | $2.00 M(+53.8%) |
| Sep 1994 | - | $1.30 M(-7.1%) |
| Jun 1994 | - | $1.40 M(+55.6%) |
| Mar 1994 | - | $900.00 K(+12.5%) |
| Dec 1993 | $800.00 K(-20.0%) | $800.00 K(-38.5%) |
| Sep 1993 | - | $1.30 M(+116.7%) |
| Jun 1993 | - | $600.00 K(0.0%) |
| Mar 1993 | - | $600.00 K(-40.0%) |
| Dec 1992 | $1.00 M(+233.3%) | $1.00 M(+66.7%) |
| Sep 1992 | - | $600.00 K(+50.0%) |
| Jun 1992 | - | $400.00 K(-87.1%) |
| Mar 1992 | - | $3.10 M(+933.3%) |
| Dec 1991 | $300.00 K(-50.0%) | $300.00 K(-92.5%) |
| Sep 1991 | - | $4.00 M(+900.0%) |
| Jun 1991 | - | $400.00 K(+33.3%) |
| Mar 1991 | - | $300.00 K(-50.0%) |
| Dec 1990 | $600.00 K(0.0%) | $600.00 K(+50.0%) |
| Sep 1990 | - | $400.00 K(-42.9%) |
| Jun 1990 | - | $700.00 K(+133.3%) |
| Mar 1990 | - | $300.00 K(-50.0%) |
| Dec 1989 | $600.00 K(+100.0%) | $600.00 K(+50.0%) |
| Sep 1989 | - | $400.00 K(+100.0%) |
| Jun 1989 | - | $200.00 K(-33.3%) |
| Dec 1988 | $300.00 K(+50.0%) | $300.00 K(+50.0%) |
| Dec 1987 | $200.00 K(-50.0%) | $200.00 K(-50.0%) |
| Dec 1986 | $400.00 K(-73.3%) | $400.00 K(-73.3%) |
| Dec 1985 | $1.50 M | $1.50 M |
FAQ
- What is Vaxart annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vaxart?
- What is Vaxart annual cash & cash equivalents year-on-year change?
- What is Vaxart quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Vaxart?
- What is Vaxart quarterly cash and cash equivalents year-on-year change?
What is Vaxart annual cash & cash equivalents?
The current annual cash & cash equivalents of VXRT is $34.76 M
What is the all time high annual cash & cash equivalents for Vaxart?
Vaxart all-time high annual cash & cash equivalents is $217.61 M
What is Vaxart annual cash & cash equivalents year-on-year change?
Over the past year, VXRT annual cash & cash equivalents has changed by -$11.26 M (-24.47%)
What is Vaxart quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VXRT is $22.04 M
What is the all time high quarterly cash and cash equivalents for Vaxart?
Vaxart all-time high quarterly cash and cash equivalents is $217.61 M
What is Vaxart quarterly cash and cash equivalents year-on-year change?
Over the past year, VXRT quarterly cash and cash equivalents has changed by -$10.41 M (-32.09%)